Processa Pharma Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Oculis Holding (OCS)
Processa Pharma Analyst Ratings
Processa Pharma Analyst Ratings
Processa Pharma Analyst Ratings
Maxim Group Sticks to Their Buy Rating for Processa Pharmaceuticals (PCSA)
Benchmark Adjusts Price Target on Processa Pharmaceuticals to $4 From $9, Keeps Speculative Buy Rating
Benchmark Maintains Speculative Buy on Processa Pharma, Lowers Price Target to $4
Oppenheimer Adjusts Processa Pharmaceuticals Price Target to $3 From $5, Maintains Outperform Rating
Oppenheimer Maintains Outperform on Processa Pharma, Lowers Price Target to $3
Maxim Adjusts Price Target on Processa Pharmaceuticals to $5 From $9, Maintains Buy Rating
Processa Pharma Analyst Ratings
Maxim Group Maintains Buy on Processa Pharma, Lowers Price Target to $5
Maxim Group Keeps Their Buy Rating on Processa Pharmaceuticals (PCSA)
Analysts Offer Insights on Healthcare Companies: Eiger Biopharmaceuticals (EIGR), Sanofi (OtherSNYNF) and Processa Pharmaceuticals (PCSA)
Analysts Offer Insights on Healthcare Companies: SELLAS Life Sciences Group (SLS) and Processa Pharmaceuticals (PCSA)
No Data